It's actually a 30% sarkar, says BJP

New Delhi, Feb 7: The Supreme Court on Friday issued a notice to the Central government on a plea challenging the Constitutional validity of the Citizenship Amendment Act (CAA) and effective implementation of the Assam Accord.

A bench of Chief Justice of India (CJI) SA Bobde also sought Centre's response on the plea filed by Assam Social Justice Forum.

The petition sought appropriate directions for taking effective steps for the implementation of Assam Accord, 1985 in letter and spirit and for conservation and preservation of the of a distinct culture, heritage and traditions of the indigenous people of Assam.

The Assam Accord, 1985, had fixed March 24, 1971, as the cut-off date for deportation of all illegal immigrants irrespective of their religion.

The Bench also sought Centre's response on another fresh batch of pleas challenging CAA and tagged them along with other petitions pending in the matter.

One of the petitions, filed by the Association of Advocates from Maharashtra among others, sought to declare the Citizenship Amendment Act as discriminatory, arbitrary, and illegal and consequently set aside the impugned act as ultra-vires the Constitution of India.

On the other hand, over a hundred petitions have been filed in the apex court, for and against the amended citizenship law, which is facing opposition and protests across the country.

CAA grants citizenship to Hindus, Sikhs, Buddhists, Jains, Parsis and Christians who fled religious persecution in Afghanistan, Bangladesh, and Pakistan and took refuge in India on or before December 31, 2014.

Bengaluru, Feb 25: A day after Karnataka minister BC Patil felt the need for a law to shoot people who raise pro-Pakistan and anti-India slogans, another BJP MLA on Monday said such people should be shot at sight or exiled to the neighbouring country.

Appachu Ranjan, MLA from Madikeri, said a woman named Amulya had raised Pakistan Zindabad slogan at Bengaluru during a CAA-related meeting.

"People saying Pakistan Zindabad, despite living in our country- eating food and drinking water available here- they should be shot at sight. Or else such people should be exiled to Pakistan, and no one should should show softness towards them and fight cases in their favour," he said at Somwarpet in Kodagu.

Amulya Leona, a woman who raised pro-Pakistan slogans at an anti-Citizenship Amendment Act rally in Bengaluru on Thursday, has been booked for sedition and remanded to judicial custody.

She had raised "Pakistan Zindabad" slogans thrice after the organisers, under the banner of "Save the Constitution", invited her to address the gathering in the presence of All India Majlis-e-Ittehadul Muslimeen (AIMIM) chief Asaduddin Owaisi.

Agriculture minister Patil on Sunday had expressed the need for a legislation to shoot such people, and said he would make a request to the prime minister in this regard. "A law should be brought in the country that who ever raises slogans against India and in favour of Pakistan, they should be shot at sight. Bringing such a law is important," Patil had said.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.